⌘K

Login Start Free

Home/Filings/4/0001104659-25-114082

4//SEC Filing

MOLINA ARTURO MD 4

Accession 0001104659-25-114082

CIK 0001377121other

View on SEC.gov Company Profile

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 4:01 PM ET

Size

5.0 KB

Accession

0001104659-25-114082

Insider Transaction Report

Form 4

Period: 2025-11-17

Protagonist Therapeutics, IncPTGX

MOLINA ARTURO MD

Chief Medical Officer

Transactions

Sale
Common Stock
2025-11-17$84.77/sh−2,712$229,896→ 81,180 total

Footnotes (1)

[F1]Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.

Documents

1 file

4
tm2531619-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Protagonist Therapeutics, Inc

CIK 0001377121

Entity typeother

Related Parties

1

filerCIK 0001398940

Filing Metadata

Form type: 4
Filed: Nov 18, 7:00 PM ET
Accepted: Nov 19, 4:01 PM ET
Size: 5.0 KB

View on SEC.gov